A social disease awareness campaign on musculoskeletal pain and associated stress during the COVID-19 pandemic
The COVID-19 pandemic has led to the shutdown of much of the world's economic and social operations with a consequent increase of the sedentary lifestyle. In addition, there has been a rise in the time of use of social media and television, especially amongst young adults, which has favoured incorrect postures.
As people have lost their normal daily activity patterns, it was noticed an increase in stress-related musculoskeletal disorders and an increase in the intensity of symptoms.
Anxiety, stiffening, cervical pain, headaches and back pain are increased, with immediate negative consequences for wellbeing and ability to access health care.
Indeed stress and musculoskeletal disorders are two conditions strictly linked, both in terms of common risk factors and the extent to which the conditions themselves are mutually influential.
Angelini Pharma launches a social disease awareness campaign involving healthcare professionals to raise awareness on the issue of increased stress-related musculoskeletal disorders during COVID-19 pandemic.
The aim of the campaign is to provide users with proper information and practical advice to deal with the problem.
Angelini Pharma believes in a multidisciplinary approach with strict collaboration amongst different professionals to improve patients’ wellbeing and health.
The campaign will take place during the week of the World Spine Day (October 11-16, 2021) and will involve three key experts: a psychologist (Dr. Lara Bellardita), a physiotherapist (Dr. Damiano Guidi) and a physiatrist (Dr. Fabrizio Gervasoni).
The experts will treat the following topics:
- How COVID-19 impacts on our physical and physchological wellbeing,
- Musculoskeletal pain as a consequence of stress, lockdown, reduced motility and sports activity,
- Smart-working: lights and shadows.
The covered topics will be disseminated with the help of influencers and social media and made available to the general public.